Wei Y - Search Results

1

Robotic natural orifice specimen extraction surgery versus robotic transabdominal specimen extraction surgery for early-stage rectal cancer: a multicenter propensity score-matched analysis (in China).

Liu D, He G, Yao H, Guan X, Wang G, Xiong D, Hu J, Yuan W, Yang C, He P, Ye S, Ju H, Yu H, Niu Z, Liu K, Tang Q, Huang R, Lian Y, Guan S, Jian J, Wei Y, Wang X, Li T. Liu D, et al. Among authors: wei y. Surg Endosc. 2024 Aug;38(8):4521-4530. doi: 10.1007/s00464-024-10995-5. Epub 2024 Jun 24. Surg Endosc. 2024. PMID: 38914889

2

Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway.

Chen J, Wei Y, Feng Q, Ren L, He G, Chang W, Zhu D, Yi T, Lin Q, Tang W, Xu J, Qin X. Chen J, et al. Among authors: wei y. Int J Oncol. 2016 Apr;48(4):1628-38. doi: 10.3892/ijo.2016.3366. Epub 2016 Feb 1. Int J Oncol. 2016. PMID: 26847263

3

Silencing homeobox C6 inhibits colorectal cancer cell proliferation.

Ji M, Feng Q, He G, Yang L, Tang W, Lao X, Zhu D, Lin Q, Xu P, Wei Y, Xu J. Ji M, et al. Among authors: wei y. Oncotarget. 2016 May 17;7(20):29216-27. doi: 10.18632/oncotarget.8703. Oncotarget. 2016. PMID: 27081081 Free PMC article.

4

Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7.

Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L, Xu J. Tang W, et al. Among authors: wei y. Onco Targets Ther. 2017 Apr 7;10:2045-2056. doi: 10.2147/OTT.S131597. eCollection 2017. Onco Targets Ther. 2017. PMID: 28435295 Free PMC article.

5

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases.

Zheng P, Ren L, Feng Q, Zhu D, Chang W, He G, Ji M, Jian M, Lin Q, Yi T, Wei Y, Xu J. Zheng P, et al. Among authors: wei y. Cancer Manag Res. 2018 Aug 27;10:2871-2881. doi: 10.2147/CMAR.S161392. eCollection 2018. Cancer Manag Res. 2018. PMID: 30214282 Free PMC article.

6

Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.

Niu Z, Tang W, Liu T, Xu P, Zhu D, Ji M, Huang W, Ren L, Wei Y, Xu J. Niu Z, et al. Among authors: wei y. Acta Biochim Biophys Sin (Shanghai). 2018 Oct 1;50(10):1007-1017. doi: 10.1093/abbs/gmy104. Acta Biochim Biophys Sin (Shanghai). 2018. PMID: 30239551 Free article.

7

Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis.

Zheng P, Liang C, Ren L, Zhu D, Feng Q, Chang W, He G, Ye L, Chen J, Lin Q, Yi T, Ji M, Niu Z, Jian M, Wei Y, Xu J. Zheng P, et al. Among authors: wei y. J Oncol. 2018 Sep 16;2018:5072987. doi: 10.1155/2018/5072987. eCollection 2018. J Oncol. 2018. PMID: 30305811 Free PMC article.

8

Patients with RAS wild-type right-sided unresectable liver-confined mCRC also benefit from cetuximab plus chemotherapy in first-line treatment.

Zheng P, Ren L, Feng Q, Zhu D, Chang W, He G, Ji M, Jian M, Lin Q, Yi T, Wei Y, Xu J. Zheng P, et al. Among authors: wei y. Am J Cancer Res. 2018 Nov 1;8(11):2337-2345. eCollection 2018. Am J Cancer Res. 2018. PMID: 30555748 Free PMC article.

9

International consensus on natural orifice specimen extraction surgery (NOSES) for colorectal cancer.

Guan X, Liu Z, Longo A, Cai JC, Tzu-Liang Chen W, Chen LC, Chun HK, Manuel da Costa Pereira J, Efetov S, Escalante R, He QS, Hu JH, Kayaalp C, Kim SH, Khan JS, Kuo LJ, Nishimura A, Nogueira F, Okuda J, Saklani A, Shafik AA, Shen MY, Son JT, Song JM, Sun DH, Uehara K, Wang GY, Wei Y, Xiong ZG, Yao HL, Yu G, Yu SJ, Zhou HT, Lee SH, Tsarkov PV, Fu CG, Wang XS; International Alliance of NOSES. Guan X, et al. Among authors: wei y. Gastroenterol Rep (Oxf). 2019 Feb;7(1):24-31. doi: 10.1093/gastro/goy055. Epub 2019 Jan 23. Gastroenterol Rep (Oxf). 2019. PMID: 30792863 Free PMC article.

10

Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.

Feng Q, Chang W, Mao Y, He G, Zheng P, Tang W, Wei Y, Ren L, Zhu D, Ji M, Tu Y, Qin X, Xu J. Feng Q, et al. Among authors: wei y. Clin Cancer Res. 2019 Jul 1;25(13):3896-3907. doi: 10.1158/1078-0432.CCR-18-2076. Epub 2019 Apr 15. Clin Cancer Res. 2019. PMID: 30988081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,810 results

Search Page

Filters